
Tags:
An article published at 9:30 AM today, October 7, 2026, on the “Queen Atletica” website reported news – already covered by various national media outlets – regarding Alex Schwazer’s decision to forgo the so-called “third sample” and NADA’s (the German anti-doping agency handling the case) willingness to alter the method used for the counter-analysis requested by the race walker.
1. Under WADA protocols, counter-analysis must be conducted using the same method employed for the initial analysis of Sample A; therefore, the analytical method must remain identical. What we requested was the additional use of a different analytical method on Sample B a step that would be scientifically advisable. NADA responded that it would consider this matter following the results of the Sample B analysis. This entire issue stems from the fact that the EPO test is an indirect test.
2. Regarding the urine sample held by Sandro Donati, the problem is that if it were to be analyzed (even privately), the resulting raw data would in WADA-accredited laboratories be processed using software called GASepo. This software is not commercially available; it is exclusive to WADA laboratories. We have never been provided with the raw data, only the data processed by the software. In short, the datasets would not be comparable.
We felt it necessary to clarify these points, as precision is essential when discussing this topic.
Original news by Luca Landoni – Queen Atletica: https://www.atleticalive.it/lentourage-di-schwazer-chiarisce-la-disponibilita-della-nada-e-perche-non-si-puo-usare-la-terza-provetta/
Cover photo by: Atleticamente Foto
